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Abstract
Introduction The standardized diagnostic criteria for comput-
ed tomographic angiography (CTA) in diagnosis of brain
death (BD) are not yet established. The aim of the study was
to compare the sensitivity and interobserver agreement of the
three previously used scales of CTA for the diagnosis of BD.
Methods Eighty-two clinically brain-dead patients underwent
CTA with a delay of 40 s after contrast injection. Catheter
angiography was used as the reference standard. CTA results
were assessed by two radiologists, and the diagnosis of BD
was established according to 10-, 7-, and 4-point scales.
Results Catheter angiography confirmed the diagnosis of BD
in all cases. Opacification of certain cerebral vessels as indi-
cator of BD was highly sensitive: cortical segments of the
middle cerebral artery (96.3 %), the internal cerebral vein
(98.8 %), and the great cerebral vein (98.8 %). Other vessels
were less sensitive: the pericallosal artery (74.4 %), cortical
segments of the posterior cerebral artery (79.3 %), and the
basilar artery (82.9 %). The sensitivities of the 10-, 7-, and 4-
point scales were 67.1, 74.4, and 96.3 %, respectively
(p<0.001). Percentage interobserver agreement in diagnosis
of BD reached 93 % for the 10-point scale, 89 % for the 7-
point scale, and 95 % for the 4-point scale (p=0.37).
Conclusions In the application of CTA to the diagnosis of
BD, reducing the assessment of vascular opacification scale
from a 10- to a 4-point scale significantly increases the sensi-
tivity and maintains high interobserver reliability.
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Introduction
The use of instrumental tests to confirm brain death (BD) is
still the subject of debate [1–3]. In North America, confirma-
tory testing is not mandatory while in certain European, Cen-
tral and South American, and Asian countries it is an obliga-
tory part of the procedure to establish BD. Nevertheless,
ancillary tests are useful when specific components of the
clinical examination cannot be reliably performed. Currently,
the most commonly used tests in Europe include electroen-
cephalography (EEG), evoked potentials, transcranial Dopp-
ler (TCD), perfusion scintigraphy using 99mTc-HMPAO or
99mTc-ECD, and catheter cerebral angiography. However, all
of them have drawbacks related to their feasibility and avail-
ability. Electrophysiological tests are susceptible to confound-
ing factors. EEG is unreliable in barbiturate overdose or deep
anesthesia and vulnerable to the hostile electrical environment
of the ICU. Evoked potentials generally can only be applied in
cases of primary supratentorial or secondary brain injuries,
because in isolated infratentorial processes they can produce
false positive results. Blood flow studies such as TCD, perfu-
sion scintigraphy, and catheter angiography are more feasible
but less available in many countries. Therefore, new imaging
methods such as magnetic resonance techniques (angiogra-
phy, spectroscopy, and diffusion-weighted imaging) and pos-
itron emission tomography have been proposed [4–7].
Recently, computed tomographic angiography (CTA)
attracted attention as a new method for the diagnosis of BD.
It appears to be a promising diagnostic alternative that is
feasible, widely available, non-invasive, and expeditious. In
1998, Dupas et al. reported the first application of CTA to the
diagnosis of BD [8]. Since then, several major studies of this
application were published, and national guidelines were intro-
duced in several countries (e.g., in France, Austria, Switzer-
land, the Netherlands, and Canada) [9–12]. Nevertheless, CTA
is not widely accepted as an ancillary test for the diagnosis of
BD. The main obstacle is insufficient diagnostic confidence of
this method [13]. Until recently, there were no standardized
criteria for interpretation of CTA results. The previous major
studies assessing CTA in the diagnosis of BD showed that
stasis of contrast in the proximal segments of cerebral arteries
is frequently found in brain-dead patients, and this phenome-
non does not preclude the diagnosis of BD. Based on those
observations, three evaluation systems have been proposed:
10-, 7-, and 4-point scales. They include different numbers of
intracranial vessels of anterior and posterior cerebral circulation
like the 10-point scale or solely anterior circulation like the 7-
and 4-point scales. The common criterion of BD in each scale
is a lack of opacification of cortical branches of the middle
cerebral arteries (MCA-M4) and the deep cerebral veins.
Another issue related to the application of CTA refers to
potential difficulty in the assessment of intracranial filling in
patients with suspected BD. As previous studies using CTA
showed intracranial vessels in these patients are markedly
thinner, and their opacification, regardless it’s level, is signif-
icantly weaker than normal [14]. Moreover, cerebral vessels
are frequently obscured by subarachnoid hemorrhage (SAH)
or increased density of subarachnoid space due to
pseudosubarachnoid hemorrhage (pseudoSAH) phenomenon,
which are frequently found in this group of patients. This can
cause difficulties in determining the level of intracranial
opacification and produce discrepant diagnoses of BD among
radiologists. Therefore, it is reasonable to question interob-
server reliability of CTA, especially with the 4-point scale, in
which the diagnosis of BD is based on the analysis of only
four vessels. Reliability was not addressed in the previous
studies, even though it can be useful in the implementation
of CTA for the diagnosis of BD.
The aim of the present study was to compare the sensitivity
and reliability of the three evaluation scales in CTA for the
diagnosis of BD. For this purpose, a single-phase CTAwith a
delay of 40 s was used. Sensitivity of CTAwas compared to
the gold standard method—catheter angiography.
Material and methods
Study population
In the prospective, multicenter study, 82 patients were
examined.
The inclusion criteria were as follows:
1. Deep unresponsive coma (GCS 3–5) of an established
etiology capable of causing neurological death.
2. Absence of brainstem reflexes:
a. Pupils mid-position or greater and absent pupillary
light reflex (fixed dilated pupils),
b. Spontaneous eye movements,





h. Vestibulo-ocular (‘cold caloric’).
The exclusion criteria were unresuscitated shock (mean
arterial blood pressure≤80 mmHg) and hypothermia (defined
as surface temperature≤35 °C). These are known depressants
of cerebral blood flow.
The study population consisted of 45 men and 37 women
with a mean age of 52.2 years (range, 22–78 years). Initial
causes of coma were traumatic brain injury (n=16), intracere-
bral hemorrhage (n=32), subarachnoid hemorrhage (n=21),
ischemic stroke (n=7), and anoxia (n=6). Decompressive
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craniectomy was performed in 26 (32 %) patients prior to exam-
inations. All patients were managed in the ICUs of two Polish
university hospitals and one multi-profile provincial hospital. All
subjects underwent cerebral CTA followed by catheter angiog-
raphy. During all examinations, patients were normoventilated,
and mean arterial blood pressure was maintained above
80 mmHg. The elapsed time between the finding of complete
brainstem areflexia and the beginning of the radiological exam-
ination ranged from 6 through 48 h (not always recorded).
Longer delays were usually caused by a prolonged initial obser-
vation period due to prior use of sedatives. Shortly, after the
radiological studies, the complete clinical testing for determi-
nation of BD was performed. According to the Polish national
legal regulations, BD was declared when coma, brainstem
areflexia, and absence of a breathing drive with 10-min CO2
challenge (apnea test) were confirmed. The apnea test result
was positive (i.e., supported the clinical diagnosis of BD) if
respiratory movements were absent and arterial PCO2 was
60 mmHg (or 20 mmHg increase in arterial PCO2 over a
baseline normal arterial PCO2). The clinical test had to be
performed twice. Brain death was declared by a commission
of three specialists, including at least one in the field of
anesthesiology and intensive care and one in the field of
neurology or neurosurgery. The majority of brain-dead patients
became organ donors. In some cases, organ donation was not
possible for medical reasons and occasionally because of a
failure to obtain permission from relatives. In such situations,
families were informed about the termination of futile therapy,
and ventilators were legally discontinued.
CTA
Two scanners were used to perform CTA: Sensation 64 (Sie-
mens, Erlangen, Germany) and Discovery CT 750 HD (GE
Healthcare, Millwaukee, USA). CTAwas preceded by a non-
enhanced CT scan, which served as a reference. After
injecting the contrast, scans were performed with a fixed delay
of 40 s. A bolus tracking technique was not used to ensure that
this CTA protocol was widely applicable nationwide; this
option is not available in all Polish CT facilities. The detailed
protocol is presented in Table 1.
In the proposed protocol, 80 ml of Iomeron 400 (Bracco
Imaging, Konstanz, Germany) was injected at a flow rate of
4 ml/s. This gave injection duration of 20 s. To determine the
appropriate delay of scanning, a time to peak concentration of
contrast in the head and neck arteries was calculated from the
formula proposed by Bae [15]:
Tpeak ¼ Tinjection þ 8s ¼ 20sþ 8s ¼ 28s
Tpeak Time to peak concentration of contrast in the head
and neck arteries
Tinjection Injection duration.
After adding 15 s to accommodate possible slowed cerebral
circulation due to increased cerebrovascular resistance and
subtracting a time needed for scanning from the level of C5/
C6 to the circle of Willis, the final formula is as follows:
Tdelay ¼ Tpeak þ 15s Tscan2 ¼ 28sþ 15s 3s ¼ 40s
Tdelay Delay of CTA scanning after contrast injection
Tscan Scan duration.
All CTA examinations were evaluated by two radiologists,
blinded to each other’s assessments, to the results of the clinical
test and to the results of the catheter angiography. They had 4
and 8 years of experience interpreting cerebral angiography.
CTA criteria of BD
Opacification of superficial temporal arteries was assessed to
confirm that the contrast was injected correctly and to detect
possible hemodynamic perturbations. The following 10 intra-
cranial vessels were evaluated:
& Pericallosal segments of the right and left anterior cerebral
artery (ACA-A3),






NECT CTA NECT CTA
Acquisition
Scan range C5/C6 to vertex
Tube voltage (KVp) 120 100 120 120
Tube current (mAs) 380 160 320 160
Rotation time (s) 1.0 0.5 1.0 0.6
Collimation (mm) 20×0.6 64×0.6 32×0.625 32×0.625
Feed (mm/rotation) 4.8 23.0 16 26.25
Pitch factor 0.8 1.2 0.8 1.2
Scan time (s) 35 6 10 6
Reconstruction
Slice width (mm) 5.0 0.6 2.5 0.6
Increment (mm) 5.0 0.4 2.5 0.6
Field of view (mm) 250 250 250 250
Matrix 512×512 512×512 512×512 512×512
RECON algorithm H31s H10f Standard Standard
Contrast injection
Start delay (s) 40 40
Volume (ml) 80 80
Flow rate (ml/s) 4 4
Injection duration (s) 20 20
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& Cortical segments of the right and left middle cerebral
artery (MCA-M4),
& Cortical segments of the right and left posterior cerebral
artery (PCA-P2),
& Basilar artery (BA),
& Right and left internal cerebral vein (ICV),
& Great cerebral vein (GCV)—the vein of Galen.
A point was given for each vessel without opacification,
resulting in scores between 0 and 10. Diagnosis of BD was
established according to the three previously used evaluation
systems: 10-, 7-, and 4-point scales—see Fig. 1. Positive result
in each scale confirming the diagnosis of BD was noted with
scores 10, 7, and 4, respectively.
Catheter cerebral angiography
All patients underwent catheter angiography as the second
part of the radiological evaluation. Angiography was per-
formed from 15 min to 3 h after CTA. Three angiographic
systems were used: Axiom Artis, Fluorospot Top (Siemens,
Erlangen, Germany), and MultiDiagnost 3 (Philips, Eindho-
ven, the Netherlands). The same technique was applied as
described previously [16–18]. A typical femoral approach
was used in all cases. In 67 patients, aortocervical angiogra-
phy was used. After positioning a Pigtail 4–5 F catheter in the
ascending aorta, 30ml of contrast was injected at a flow rate of
15 ml/s. In the remaining 15 patients, carotid and vertebral
arteries were catheterized selectively; 8 ml of contrast was
injected into each artery at a flow rate of 8 ml/s. We visualized
the head and neck by recording 50-s series with a frequency of
2 f/s and using a digital subtraction technique. A local neuro-
radiologist performed and assessed all studies.
Angiographic criteria of BD
Cerebral circulatory arrest was diagnosed by catheter angiog-
raphy if either of the following criteria were met:
& Non-filling of intracranial vessels with the normal flow in
the external carotid arteries,
& Stasis filling—delayed, weak, and persistent opacification
of the proximal cerebral arterial segments without
opacification of the cortical branches or venous outflow.
Data collection
Demographic data recorded for brain-dead patients were age
and sex. Clinical data were initial cause of coma, the presence
of craniectomy, SAH, or pseudoSAH. PseudoSAH is well-
known phenomenon of increased attenuation of the subarach-
noid space mimicking SAH. For the diagnosis of BD in CTA
and catheter angiography, opacification of the following ves-
sels was recorded:
& Superficial temporal arteries (STA),
& Pericallosal segments of the right and left anterior cerebral
artery (ACA-A3),
& Cortical segments of the right and left middle cerebral
artery (MCA-M4),
& Cortical segments of the right and left posterior cerebral
artery (PCA-P2),
& Basilar artery (BA),
& Right and left internal cerebral vein (ICV),
& Great cerebral vein (GCV)—the vein of Galen.
The presence of stasis filling in CTA and catheter angiog-
raphy was also noted. Stasis filling was defined as
opacification of one or more of the following arterial
segments:
& ACA–A1 and A2,
& MCA–M1, M2, and M3,
& PCA–P1 without opacification of the cortical arterial
branches or deep veins.
Fig. 1 Different criteria for the diagnosis of BD byCTA: a Positive result
in the 10-point scale (score=10) confirming the diagnosis of BD was
recorded when the following vessels were not opacified: the bilateral
PCA-P2, the BA, the bilateral ACA-A3, the bilateral MCA-M4, the
bilateral ICV, and the GCV. Scores from 0 to 9 were classified as negative
results excluding the diagnosis of BD; b In the 7-point scale, positive
result (score=7) was recorded with a lack of opacification of the bilateral
ACA-A3, the bilateral MCA-M4, the bilateral ICV, and the GCV. Scores
from 0 to 6 were classified as negative results; c Positive result in the 4-
point scale (score=4) was recorded when the bilateral MCA-M4 and the
bilateral ICV were not opacified. Scores from 0 to 3 were classified as
negative results
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Two radiologists independently evaluated each CTA and
recorded the diagnosis of BD using the 10-, 7-, and 4-point
scales. A false negative result of CTAwas noted when the test
precluded BD otherwise confirmed by catheter angiography
and clinical testing. A true positive result of CTAwas recorded
when CTA, catheter angiography, and clinical testing concor-
dantly confirmed BD.
Statistical analysis
Interobserver agreement was measured by the Kendall’s tau-b
rank correlation coefficient for dichotomous variables (diag-
nosis of BD). The significance of interobserver differences
was assessed by McNemar’s test. Cochran’s Q test was used
to compare the proportion of false negative results of BD
diagnosis between scales. A multivariate logistic regression
model with sex, age, presence of craniectomy, and occurrence
of SAH/pseudoSAH as independent variables was used to
find independent predictors of false negative CTA results.
P<0.05 was considered statistically significant. STATISTICA
10 software (StatSoft, Tulsa, USA) was used for the statistical
analyses. The tests were evaluated by a medical statistician.
Results
In all 82 cases, clinical tests confirmed BD. Catheter angiog-
raphy results were consistent with the diagnosis of BD in all
cases, revealing no intracranial filling in 62 (75.6 %) patients
with the normal flow in the external carotid arteries. Stasis
filling was observed in 20 (24.4 %) patients. This phenome-
non was observed from 4 to 48 s after intraarterial injection.
No venous outflow was observed in any case.
The analysis of interobserver agreement did not reveal
significant differences between the two radiologists who
assessed CTA for the diagnosis of BD; see Table 2.
There were 19 discordant diagnoses of BD between radi-
ologists analyzing CTA. Both radiologists jointly revised each
discrepant finding to reach a consensus, which is presented in
the following CTA results.
All CTA examinations revealed opacification of the STA
with no discrepancies noted between radiologists (percentage
agreement was 100 %).
Analysis of opacification of particular cerebral vessels in
CTA revealed that they could be classified into the following
two groups:
& Frequently opacified vessels: the ACA-A3 (in 21 pa-
tients), PCA-P2 (17), and BA (14),
& Rarely opacified vessels: MCA-M4 (3 patients), ICV (1),
and GCV (1), see Table 3.
Regarding their sensitivity as indicators of cerebral circu-
latory arrest, the high sensitivity group included cortical seg-
ments of the MCA, ICV, and GCV. The low sensitivity group
consisted of the pericallosal artery and cortical segments of the
PCA and BA. The sensitivities of all six vessels differed
significantly (p<0.001, Cochran’s Q test). There were no
significant differences between vessels within the high sensi-
tivity group and the low sensitivity group, see Fig. 2.
According to the 10-point scale, 27 false negative CTA results
were observed, see Fig. 3. With the 7-point scale, the number of
false negative results decreased to 21, see Fig. 4. The 4-point
scale provided three false negative results, see Fig. 5. A compar-
ison of sensitivities for different CTA scales is presented in Fig. 6.
According to the 10-point scale, CTA showed a non-filling
pattern in 32 (39 %) patients and stasis filling in 23 (28 %)
patients.
Sex, age, presence of craniectomy, and the occurrence of
SAH/pseudoSAH were analyzed as independent predictors of
a false negative CTA result in the 10-point scale. Presence of
craniectomy appeared to be an independent predictive factor
of a false negative CTA. Relative risk of a false negative CTA
in patients with craniectomy was 3.13 times higher than in
those without it (95 % CI=1.70 to 5.77; p=0.0002). The
second independent predictor of a false negative CTA was
the presence of SAH/pseudoSAH observed in 54 patients.
Relative risk of a false negative CTA in patients with SAH/
pseudoSAH was 2.98 times higher than in those without it
(95 % CI=1.14 to 7.78; p=0.0255). Sex and age were not
associated with false negative CTA results.
Discussion
The percents of agreement between the radiologists were
equally high (89–95 %) for all scales. The fact that the ob-
servers did not reach perfect agreement could be explained by
significantly lower contrast enhancement of cerebral arteries
in brain-dead patients compared to normal opacification [14].
However, the analysis of interobserver agreement showed a
trend towards lower values of Kendall’s tau-b coefficient
using the 4-point scale. Interobserver agreement coefficients,
including tau-b, are affected by the prevalence of measures
under consideration; therefore, low values of tau-b may be due
to rare findings, such as negative CTA results using the 4-
Table 2 Interobserver agreement in the diagnosis of BD
Scale tau-b Percentage agreement p value
10-point 0.84 93 0.68 (ns)
7-point 0.71 89 0.50 (ns)
4-point 0.64 95 0.13 (ns)
Note: p for systematic difference between radiologists (McNemar’s test);
ns not significant
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point scale, may not reflect low rates of agreement. This is a
known paradox explained by Feinstein and Cicchetti [19, 20].
In such situations, the percentage agreement is more reliable
indicator of interobserver concordance.
Concerning opacification of individual cerebral vessels as
indicators of cerebral circulatory arrest, two groups can be
distinguished:
& High sensitivity: MCA, ICV, and GCV,
& Low sensitivity: ACA, PCA, and BA.
In previous studies, different sets of vessels were consid-
ered in the diagnosis of cerebral circulatory arrest [8, 21–26].
The first evaluation scale was introduced by Dupas et al. in
1998 [8]. They observed 100 % sensitivity and specificity of
the pericallosal artery, MCA-M4, ICV, and GCV, and pro-
posed the 7-point system, which excluded arteries of the
posterior cerebral circulation, because their sensitivity was
lower (85.7 % for BA). Delayed opacification of the BA in
clinically brain-dead patients was observed in several studies
using catheter angiography [27–31]. Braun et al. reported this
phenomenon in 24 (17 %) of 140 patients meeting clinical
criteria of BD; these findings were verified by positive TCD in
six cases [31]. Only four previous studies assessed
opacification of the BA with CTA in BD [8, 21, 23, 25].
Combes et al. reported a 100 % sensitivity of the BA [25];
however, the other authors observed sensitivities that
ranged from 86 to 94 %. These later results are consis-
tent with our finding for the BA, 82.9 % sensitivity.
Simultaneously, in all cases, catheter angiography showed a
lack of opacification of BA in the 30- to 50-s series. In the
study by Welschehold et al., all cases were verified by a
positive TCD result [21]. These findings show that
opacification of BA can be observed in up to 17 % of brain-
dead patients and does not indicate preserved cerebral perfu-
sion, thus does not preclude diagnosis of BD. A high frequen-
cy of BA opacification in brain-dead patients can be explained
by the protective role of the cerebellar tentorium. The majority
of primary brain injuries affect the supratentorial compart-
ment; therefore, increasing intracranial pressure (ICP) primar-
ily stops capillary and venous flow to the cerebral hemi-
spheres. In these injuries, ICP may rise more slowly in the
infratentorial region, allowing contrast to enter arteries of
posterior cerebral circulation. Cessation of flow in posterior
cranial fossa can occur with a delay, providing false negative
results of blood flow examinations. One of such cases is
presented in Fig. 3.
Fig. 2 Sensitivity of cerebral vessels as indicators of cerebral circulatory
arrest in CTA. All vessels were classified into the high sensitivity group
(cortical segments of the MCA, ICV, and GCV) and the low sensitivity
group (the pericallosal artery and cortical segments of the PCA and BA)
Fig. 3 CTA findings in a 50-year-old man (patient no. 45) with traumatic
brain injury (epidural hematoma in the right parietal region, massive
intracerebral, and subarachnoid and intraventricular hemorrhage) and
right sided craniectomy presented with signs of BD on clinical examina-
tion: a Ten millimeter maximum intensity projection (MIP) in sagittal
plane. CTA shows opacification of the BA (thin arrow) and a trace of
contrast in A2 segments of the ACAs (thick arrow). b TenmillimeterMIP
in coronal plane. CTA shows opacification of the M1 segment of the left
MCA (thin arrow) and the A1 segments of the ACAs (thick arrow); these
findings exclude the diagnosis of BD according to the 10-point scale but
confirm BD according to the 7- and 4-point scales. c Catheter angiogra-
phy of the right VA performed 0.5 h later revealed delayed, residual filling
of the BA (arrow) that occurred 21 s after injection. This result was
interpreted as stasis filling consistent with the diagnosis of BD
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In regard to the diagnostic value of pericallosal artery, the
100 % sensitivity observed by Dupas et al. was not confirmed
in other studies that reported a sensitivity of 57–83 % for this
artery [8, 21–25]. In this study, the pericallosal artery had the
lowest level among all the vessels evaluated. The shorter
distance from the skull base to the pericallosal artery, in
comparison with the MCA-M4, can explain the lower sensi-
tivity of the ACA-A3 for the CTA diagnosis of BD. According
to Poisseuille’s equation, cerebral blood flow (CBF) is in-
versely proportional to the length of the vessel.
CBF ¼ π CPP radius
4
8 viscosity length
CPP Cerebral perfusion pressure
Radius Radius of the vessel
Viscosity Viscosity of the blood
Length Length of the vessel.
Therefore, raised ICP primarily stops the flow in the distal
cortical segments of the MCA, whereas the contrasts column
continues to reach more proximal pericallosal arteries for
some time. One such case is presented in Fig. 4.
A high frequency of opacification of ACA-A3 in brain-
dead patients is the principal cause of the low sensitivity of
CTA in the 10- and 7-point scales previously reported and
confirmed by this study, see Table 4.
In 2006, Leclerc et al. introduced the 4-point scale, which is
limited to the most sensitive parameters, the MCA and ICV,
and excludes the ACA and GCV [26]. Exclusion of GCV was
motivated by the fact that it drains blood partially from the
posterior circulation. Therefore, this was a consequence of
exclusion of the BA and PCA. In addition, circulation to the
Fig. 4 CTA findings in a 22-year-old woman (patient no. 42) with a brain
stem ischemic stroke and a right sided craniectomy who presented with
signs of BD on clinical examination. a Ten millimeter MIP in sagittal
plane. CTA shows opacification of the right pericallosal artery (thin
arrows); b TenmillimeterMIP in coronal plane. CTA shows opacification
of the M1 segments of the MCAs (thin arrows). These findings exclude
the diagnosis of BD according to the 10- and 7-point scales but confirm
BD according to the 4-point scale. c Catheter angiography from the aortic
arch performed 1 h later revealed delayed, residual filling of the M1
segment of the right MCA (thick arrow) and A2 segment of the right
ACA (thin arrow) that occurred 32 s after injection. This result was
interpreted as stasis filling consistent with the diagnosis of BD
Fig. 5 CTA findings in a 34-year-old woman (patient no. 44) with brain
stem hematoma and frontal craniotomy presenting signs of BD on clinical
examination. a Ten millimeter MIP in sagittal plane. CTA shows
opacification of both pericallosal arteries (thin arrows); b Ten millimeter
MIP in coronal plane. CTA shows opacification of the cortical segments
of the MCAs (thin arrows); these findings exclude the diagnosis of BD
according to the 10-, 7-, and 4-point scales. c Catheter angiography of the
right ICA performed 3 h later revealed delayed, residual filling of the M1
segments of the MCAs (thin arrows) and the A2 segments of the ACAs
(thick arrow) that occurred 18 s after injection. This result was interpreted
as stasis filling consistent with the diagnosis of BD
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basal ganglia is assessed by opacification of the ICVs; there-
fore, opacification of the GCV, a confluence of the ICVs, does
not provide any additional information, despite its high indi-
vidual sensitivity. This approach was included in the recom-
mendations of the French Society of Neuroradiology. The
GCV was included in their earlier, 2007, recommendations,
but was excluded from their most recent, 2011, revised rec-
ommendations [12, 32]. To summarize, evaluation of CTA in
the diagnosis of BD evolved from the 10- and 7-point systems
to the more highly sensitive 4-point scale.
It must be noted that respecting the widely accepted con-
cept of the whole brain death, an ancillary test should assess
the perfusion of the entire brain including anterior and poste-
rior circulation. This condition is not fulfilled in the 7- and 4-
point scales limited to anterior circulation. However, some
established ancillary tests do not entirely address this issue
either. TCD for the diagnosis of BD consists of assessing
blood flow in MCAs and BA, omitting ACAs and PCAs.
There are opinions that in planar radionuclide perfusion ex-
amination it is difficult to evaluate the perfusion of the
brainstem because of overlying parotid gland and other soft
tissues [33]. Evoked potentials allow examination of specific
areas of interest in the brainstem. Finally, EEG records activity
from only the cortical layers immediately beneath the scalp; it
does not record from subcortical structures, such as the
brainstem or thalamus. It should be considered that ancillary
test, even if limited to assessment of the anterior circulation, is
always combined with the clinical examination testing
brainstem function. Besides, no false positive result of CTA
according to 7- or 4-point scale has been reported so far (i.e.,
CTA confirmed BD, yet the patient survived).
While analyzing a relationship between demographic and
clinical features, and the sensitivity of CTA, it was found that
craniectomy independently predisposed to false negative re-
sults. Preserved intracranial opacification in brain-dead pa-
tients with skull defects, particularly craniectomy, was previ-
ously reported [22, 23, 30, 31, 34]. Three of such cases are
presented in Figs. 3, 4, and 5. This can be explained by
regional reduction of ICP caused by a skull defect. Alvarez
et al. postulated that intracranial hypertension is nevertheless
severe enough to induce cerebral circulatory arrest in these
cases [30]. However, the residual cerebral flow at the region of
the skull defect is a major limitation of perfusion tests for
confirmation of BD. Frampas et al. recommended a minimum
observation period of 6 h before CTA in this clinical situation
because of the slow increase of ICP [23].
SAH or pseudoSAH appeared to be a second factor that
predisposed to false negative CTA results. This finding may
be explained by increased baseline density of the subarach-
noid space in patients with SAH or pseudoSAH, which can be
mistaken for a true vascular opacification. These findings
support the observation of Gutierrez et al. that interpretation
of CT can be difficult in such circumstances [35].
In many patients, catheter angiography showed more prox-
imal intracranial opacification than did CTA. Dupas et al.
observed the same divergence in four of seven cases [8]. A
larger volume of contrast was used in CTA than in catheter
angiography, but during angiography, contrast was injected
intra-arterially, which minimizes the dilutional effect. This
discrepancy could have resulted from the sequence in which
CTA and catheter angiography were performed. Angiography
was performed from 15min to 3 h after CTA. During this time
interval, a slowly rising ICP could further suppress cerebral
circulation and stop contrast movement at more proximal
levels.
The proposed CTA protocol differs from the standard
technique of CTA in the diagnosis of BD consisting of NECT
and two post-contrast phases started at 20 and 60 s after
injection [36]. The 20- to 60-s protocol was proposed by
Dupas et al. in 1998 [8] and was applied in several later studies
[21–26]. However, in clinical practice, particularly in France,
Fig. 6 Sensitivity of three CTA scales for the diagnosis of BD. The
sensitivities differed significantly (p<0.001, Cochran’s Q test)
Table 4 Results of the major studies that evaluated the sensitivity of
CTA for the diagnosis of BD by the type of scale utilized
Study authors and year Sensitivity (%)
10-point 7-point 4-point
Combes et al. 2007 [25] 70
Welschehold et al. * 2013 [21] 54
Dupas et al. 1998 [8] 100
Quesnel et al. ** 2007 [24] 52
Frampas et al. 2009 [23] 63 86
Rieke et al. 2011 [22] 76 93
Leclerc et al. 2006 [26] 87
Present study 67.1 74.4 96.3
Note: *GCV was not assessed, **This study included 5 (of 21) patients
with anoxic brain injury, which predisposes to preserved residual
perfusion
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it is routinely combined with whole body CT for assessing
transplantable organs with a single contrast injection. Such
combination requires a larger volume of contrast (120 ml
instead of ≈80 ml) and longer injection duration (40 s instead
of ≈20 s) in comparison to a standard CTA of the brain.
The technique proposed in the present study is dedicated
for assessing cerebral vessels, as whole body CT was not
included in the examination. Therefore, a volume of contrast
was reduced to 80 ml—a standard for cerebral CTA. A stan-
dard flow rate of 4 ml/s was used as well. This gave injection
duration of 20 s—twice as shorter in comparison to the 20- to
60-s protocol. While choosing a proper delay of CTA scan-
ning for the diagnosis of BD, one must take into account that
in some cases cerebral circulation may be slowed due to
intracranial hypertension. A key issue is to cover this delayed
vascular opacification with CTA scanning. As perfusion and
angiographic studies show, there is a threshold time of ap-
proximately 15 s for cerebral circulation to preserve a viability
of the brain [28, 37–41]. With longer circulation time, an
opacification of cerebral vessels does not indicate preserved
brain perfusion thus does not preclude the diagnosis of BD.
Thus, optimal CTA scan for the diagnosis of BD should be
performed approximately 15 s after peak concentration of
contrast is achieved in the head and neck arteries. This time
is 40 s after injection with the injection duration of 20 s used in
the present study. It should be noted that the standard 60-s
phase is also performed approximately 15 s after peak con-
centration of contrast in the head and neck arteries, because
the standard protocol includes the 40-s injection duration.
Applying the injection duration of 20 s and following the
standard protocol with scanning at 60 s after injection would
be consistent with assessing vascular opacification over 30 s
after peak contrast concentration in the head and neck arteries.
This would detect extremely slow cerebral circulation not
indicative of preserved perfusion but providing false negative
results and decreasing the sensitivity of CTA.
Another difference between the proposed protocol and the
20- to 60-s technique is an abandonment of the early 20-s
phase. The early phase is used for assessing of opacification of
extracranial arteries as an indicator of sufficient contrast de-
livery. However, the study by Leclerc et al. showed that
extracranial arteries are similarly opacified in the 20-s and in
the 60-s phase [26]. They postulated that the scanning proto-
col could be limited to a single, 60-s phase. Therefore, it was
reasonable to assume that scanning with a delay of 40 s will be
sufficient to detect opacification of extracranial arteries. The
results confirmed these assumptions because all CTA exami-
nations revealed sufficient opacification of the STA. The
proposed single-phase protocol can be a feasible alternative
to the two-phase technique in the diagnosis of BD, when
whole body CT is not simultaneously performed. In compar-
ison to the two-phase protocol, the single-phase method is
simpler to perform and requires a lower volume of contrast,
which is less harmful for the kidneys. However, the accuracy
of both protocols needs to be comparatively evaluated.
Limitations
The study was limited to one measure, sensitivity, of the
accuracy of CTA for the diagnosis of BD. To more completely
describe the accuracy of CTA for the diagnosis of BD, assess-
ment of its specificity is needed, preferably with a control
group, including comatose patients at different degrees of
intracranial hypertension.
Conclusions
In the application of CTA for the diagnosis of BD, reducing
the assessment of vascular opacification scale from a 10- to a
4-point scale significantly increases the sensitivity and main-
tains high interobserver reliability. Therefore, the 4-point scale
seems to be optimal in the determination of BD. Nevertheless,
introduction of CTA as reliable ancillary test cannot be rec-
ommended without evaluation of its specificity, which has not
been comprehensively studied yet.
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